Method of Detecting Hepatitis B Virus S Antigen

US20080193916A1Active Publication Date: 2008-08-14ADVANCED LIFE SCI INST
2 Cites 6 Cited by

Patent Information

Authority / Receiving Office
US · United States
Current Assignee / Owner
Publication Date
2008-08-14

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

[PROBLEMS] To provide a probe useful in the detection of HBV or HBs antigen by which an escape mutant of hepatitis B virus (HBV) possibly occurring in a specimen can be detected; and a method of using the same.[MEANS FOR SOLVING PROBLEMS]A probe capable of recognizing an epitope located on a peptide comprising the amino acid sequence of SEQ ID NO:1; and a method of detecting hepatitis B virus or hepatitis B virus s antigen by using this probe.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present invention relates to a probe recognizing a novel epitope of hepatitis B virus (HBV) s antigen (HBs antigen) and a method of detecting HBV, or HBs antigen, by using the probe.BACKGROUND ART

[0002] Diagnosis of viral infection is carried out mainly by a method of detecting a virus or a virus-related component (protein or nucleic acid) or by a method of detecting a specific antibody produced by the living body upon viral infection.

[0003] Usually, infection with HBV can be known by confirming the presence of HBs antigen or HBc antibody. As an indicator not only for infection with HBV but also for a clinical state of an HBV carrier or judgment of prognosis and treatment efficacy, the amount of hepatitis B virus e antigen (HBe antigen), an antibody to the antigen, or DNA of HBV (HBV-DNA) is measured.

[0004] Among antigens constituting HBV viral particles (HBV particles), HBs antigen is a major constitutional envelope protein on the surface of infectious HBV par...

Examples

example 1

Expression and Purification of TrpE-HBs (26 to 80) Antigen

(A) Construction of TrpE-HBs (26 to 80) Antigen-Expressing Plasmid

[0053]An expression plasmid for HBs (26 to 80) region was constructed by the following method. 100 μl serum from an HBV patient was mixed with 100 μl DNA extract [10 μl of 1 M Tris-HCl (pH 8.4), 8 μl of 250 mM EDTA, 40 μl of 10% SDS, 8 μl of 5 M NaCl, 10 μl of 20 mg / ml. Proteinase K, 1 μl tRNA (5 μg / μl), and 23 μl sterilized water] and incubated at 54° C. for 30 minutes. The sample was mixed with 200 μl phenol / chloroform (1 / 1) solution and then centrifuged at 15 Krpm for 5 minutes to give a supernatant, and 150 μl isopropanol and 7 μl of 5 M NaCl were added to the supernatant and left at −20° C. for 1 hour. After centrifugation at 15 Krpm at 4° C. for 5 minutes, the precipitates were rinsed with 70% ethanol and then centrifuged again at 15 Krpm at 4° C. for 5 minutes. The precipitates were air-dried and dissolved in 20 μl sterilized water to give an HBV DNA sol...

example 2

Preparation of Hybridoma

[0061]The polypeptide [trpE-HBs (26 to 80)] prepared by the method described above was dissolved with 6M urea and then diluted at a final concentration of 0.2 to 1.0 mg / ml in 10 mM phosphate buffer (pH 7.3) containing 0.15 M NaCl (PBS), then mixed with an equal volume of Freund's adjuvant, and administered intraperitoneally in a dose of 10 to 20 μg to a 4- to 6-week-old BALB / c mouse.

[0062]Booster was carried out every 2 to 4 weeks in the same manner as above, and for final immunization, 10 μg HBs dissolved in PBS was administered to the caudal vein.

[0063]At three days after the final immunization, the spleen was aseptically removed from the mouse, then broken into individual cells with scissors and a metallic mesh and washed 3 times with RPMI-1640 medium. Mouse myeloma cell strain Sp2 / OAg14 at the logarithmic growth phase was washed 3 times with RPMI-1640 medium, and the cells were mixed with the spleen cells at a ratio of 1:5. After centrifugation at 200×g f...

example 3

Preparation and Analysis of Monoclonal Antibody

[0066]Each of the hybridomas obtained by the method described in Example 2 was transplanted in a BALB / c mouse abdominal cavity previously administered with pristane, and the monoclonal antibody produced in the ascites was obtained.

[0067]The IgG fraction containing the monoclonal antibody was purified by affinity chromatography on a protein A Sepharose column.

[0068]The respective obtained monoclonal antibodies were analyzed for their target epitope by using the TrpE-HBs (26 to 80) antigen and synthetic peptides each consisting of 20 amino acids synthesized on the basis of a sequence derived from the HBs region, and as a result, it was found that as shown in Table 1, these monoclonal antibodies recognize an epitope (amino acid numbers: 26 to 80) of the HBs antigen, which is located in the inside of a lipid bilayer.

[Table 1]

[0069]

TABLE 1(Poly)peptideAmino acidMonoclonal antibody namenamenumber4A36G61C10HBS-1 1-20−−−HBS-211-30−−−HBS-321-40−...